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  19 
Summary 20 
During the last decade, West Nile virus (WNV) outbreaks have increased sharply in 21 
both horses and human in Europe. The aims of this study were to evaluate characteristics 22 
and spatio-temporal distribution of WNV outbreaks in horses in Spain between 2010 and 23 
2016 in order to identify the environmental variables most associated with WNV 24 
occurrence and to generate high-resolution WNV suitability maps to inform risk-based 25 
surveillance strategies in this country. Between August 2010 and November 2016, a total of 26 
403 WNV suspected cases were investigated, of which 177 (43.9%) were laboratory 27 
confirmed. Mean values of morbidity, mortality and case fatality rates were respectively 28 
7.5%, 1.6% and 21.2%, respectively. The most common clinical symptoms were: 29 
tiredness/apathy, recumbency, muscular tremor, ataxia, incoordination and hyperesthesia. 30 
The outbreaks confirmed during the last seven years, with detection of WNV RNA lineage 31 
1 in 2010, 2012, 2013, 2015, 2016, suggest an endemic circulation of the virus in Spain.  32 
The spatio-temporal distribution of WNV outbreaks in Spain was not homogeneous, as 33 
most of them (92.7%) were concentrated in western part of Andalusia (southern Spain) and 34 
significant clusters were detected in this region in two non-consecutive years. These 35 
findings were supported by the results of the space-time scan statistics permutation model. 36 
A presence-only MaxEnt ecological niche model was used to generate a suitability map for 37 
WNV occurrence in Andalusia. The most important predictors selected by the ENM were: 38 
mean annual temperature (49.5% contribution), presence of Culex pipiens (19.5% 39 
contribution), mean annual precipitation (16.1% contribution) and distance to Ramsar 40 
wetlands (14.9% contribution). Our results constitute an important step for understanding 41 
WNV emergence and spread in Spain and will provide valuable information for the 42 
development of more cost-effective surveillance and control programs and improve the 43 
protection of horse and human populations in WNV endemic areas. 44 
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  48 
Introduction 49 
West Nile disease (WND) is a re-emerging zoonotic disease in Europe and 50 
neighboring countries. The causative agent, West Nile Virus (WNV), is a positive, single-51 
stranded, enveloped RNA virus classified within the Japanese encephalitis virus serogroup, 52 
in the genus Flavivirus (family Flaviviridae). To date, seven (or nine according to some 53 
authors) different WNV lineages have been identified, but only lineage 1 and 2 have been 54 
associated with human and horse cases (Rizzoli et al., 2015).  55 
The virus is mainly transmitted by ornithophilic mosquitoes of the Culex pipiens 56 
complex and their hybrids in an enzootic life-cycle in which certain birds act as natural 57 
reservoir hosts, amplifying the virus. Although mammals are susceptible to infection, most 58 
are considered dead-end or incidental hosts, as the viraemia is too low to infect competent 59 
vectors. Humans can also become infected by blood transfusion, organ transplantation, 60 
intrauterine transmission, handling of infected carcasses and breast feeding (CDC, 2017). In 61 
general, WNV infection in humans and horses is asymptomatic or associated with 62 
influenza-like illness; however, in some cases (< 1%) the infection can lead to severe 63 
neurological symptoms and mortality (Hayes et al., 2005). 64 
Compared with the rapid and widespread distribution of WNV in the United States 65 
after its introduction in 1999 (CDC, 2017), in Europe, WNV was initially considered to 66 
have minor health effects, with sporadic cases in human and horses. However, the number 67 
of notified WNV outbreaks caused by both lineage 1 and lineage 2 has significantly 68 
increased in Mediterranean Basin during the last decade, which has raised concerns in 69 
relation to both public and animal health (Hernández-Triana et al., 2014; Benjelloun et al., 70 
2016).  71 
Before the 2010 WNV epidemic in Spain, antibodies had already been detected in 72 
humans, horses and wild bird species, but only sporadic clinical cases were reported in 73 
humans and raptors in Spain (Kaptoul et al., 2007; Jiménez-Clavero et al., 2008; García-74 
Bocanegra et al., 2011a). In late summer 2010, the first WNV horse outbreak was reported 75 
in southern Spain (Andalusia). Throughout that year, 35 further cases were reported in 76 
horses, and also 2 human cases were confirmed in the region (García-Bocanegra et al., 77 
2011b). Since then, WNV outbreaks in horses have been reported every year. The goals of 78 
this study were: (1) to describe the main epidemiological and clinical findings of the WNV 79 
outbreaks in horses during the period 2010-2016 in Spain, (2) to assess the spatio-temporal 80 
distribution of WNV, and (3) to identifying the drivers of WNV occurrence in the endemic 81 
areas in Spain using a presence only maximum entropy ecological niche model. 82 
Materials and methods 83 
Descriptive analysis 84 
After the confirmation of the first WNV outbreak in a horse herd on the 31st of 85 
August 2010, a passive surveillance system which included horses, humans, wild birds, and 86 
mosquitoes was launched by the veterinary and health authorities in Spain. All the herds in 87 
which horses with clinical symptoms compatible with WND were observed, were 88 
investigated by veterinary officers. Blood samples were obtained from suspected horses by 89 
puncture of the jugular vein. Brain and cerebrospinal fluid samples were also collected 90 
from dead or euthanized animals.  91 
Serum samples from all investigated horses were tested to detect IgM antibodies 92 
against WNV using a commercial competitive ELISA (cELISA; IDEXX IgM WNV Ab, 93 
IDEXX Lab). Furthermore, 248 of the 403 (61.5%) investigated herds (including 115 94 
IgM-positive herds and 133 IgM-negative herds) were randomly selected and analyzed 95 
by a commercial blocking ELISA (bELISA; Ingezim West Nile compac R.10.WNV.K3, 96 
Ingenasa Lab), which detects IgG antibodies against one epitope of the prM-E protein of 97 
the flaviviruses of the Japanese Encephalitis antigenic group. Both ELISAs were performed 98 
according to the manufacturer’s recommendations. Ninety-four of 177 (53.1%) of the 99 
IgM-positive herds, as well as 31 of 133 (23.3%) of the IgM-negative herds, were 100 
selected, using a convenience sampling, and analyzed also by virus serum-neutralization 101 
test (VNT) against WNV (strain Eg101) according to the OIE guidelines (Table 1). Blood 102 
and cerebrospinal fluid samples (CFS) were analyzed for detection of WNV lineage 1 and 2 103 
by real time RT-PCR as previously described (Del Amo et al., 2013). All laboratory tests 104 
were performed at the National WNV Reference Laboratory in Algete (Madrid, Spain). 105 
An outbreak was defined as a herd with at least one confirmed case. A case was 106 
defined as a horse with clinical symptoms that were compatible with WND and confirmed 107 
by the National Reference Laboratory as positive by detection of IgM antibodies to WNV 108 
or RT-PCR positivity. The WNV-specific morbidity was expressed as the number of WND 109 
cases in the investigated horse herds divided by the total number of horses in these affected 110 
herds. The WNV-specific mortality was calculated as the number of deaths due to WNV 111 
infection divided by the total number of horses in the confirmed herds. The WNV-specific 112 
case fatality was expressed as the proportion cases that died of WNV infection by the total 113 
number of WND cases. 114 
Epidemiological data were collected during clinical inspections using a standardized 115 
questionnaire in Andalusia, the region where the majority of outbreaks (92.7%) were 116 
reported. Information on the characteristics of the herds and affected animals was also 117 
recorded in this region for the descriptive analysis. 118 
Spatio-temporal cluster analysis 119 
A spatio-temporal analysis was carried out in Andalusia. Geolocations (UTM 120 
coordinates) of all investigated horse herds were provided by the Regional Government of 121 
Andalusia and the Spanish Ministry of Agriculture Food and Environment. Data from 122 
August 2010 to November 2016 were analyzed using a space-time scan statistic, with a 123 
space-time permutation model (Kulldorff et al., 2005), to detect the presence of areas and 124 
time periods with significant aggregation of WNV outbreaks in horse herds. Space-time 125 
permutation model, similarly to the other more commonly used Bernoulli- and Poisson- 126 
based models, creates thousands of overlapping cylinders over the study area and compare 127 
the observed number of cases within the cylinder (i.e., at particular space -based of the 128 
cylinder- and particular time -height of the cylinder-) to the "expected" number of cases in 129 
that cylinder. The main difference of the permutation model is that the expected is 130 
calculated using only the cases as described by Kulldorff et al, 2005. The maximum spatial 131 
and temporal window were set up to be 50% of the study region surface and 15% of the 132 
study period (one year), respectively. The number of Monte Carlo simulations was set to 133 
999 for the cluster scan statistic. Analyses were run using SaTScanTM v9.4.4. Clusters were 134 
considered to be significant at P < 0.05. 135 
Ecological Niche Modeling  136 
Risk areas for WNV outbreaks occurrence in Andalusia were detected using the 137 
presence-only maximum entropy ecological niche model (MaxEnt) (Phillips et al., 2006). 138 
The model was performed with the MaxEnt program version 3.3.3 via the “dismo” package 139 
in R Studio version 1.0.44 (Hijmans et al., 2016). Briefly, the maximum entropy ecological 140 
niche model looks at the association between the presence data and several environmental 141 
predictors known to be related to the disease in order to characterize the most important 142 
environmental requirements for the disease agent to be present and estimate a suitability 143 
probability in sampled and non-sampled geographic areas.  144 
In order to determine the suitability area for WNV occurrence in Andalusia, the 145 
MaxEnt model used the WNV outbreaks locations in the region between 2010 and 2016 as 146 
presence data and 10.000 randomly chosen background points from Andalucía as “Pseudo-147 
Absence” data. Potential predictors for the MaxEnt model consisted of a set of 14 climatic, 148 
environmental and demographic factors that were previously described as important for 149 
WNV presence. The model was calibrated with a default convergence threshold, a 150 
regularization of 1 and a number of iterations of 1,000. In addition, a logistic model was 151 
used to ensure that predictions gave estimates between 0 and 1 for the spatial suitability per 152 
map cell. Climatic predictors were provided by the Regional Government of Andalusia 153 
(CMAOT, 2016). They included mean annual temperature (ºC), mean maximum annual 154 
temperature (ºC), mean minimum annual temperature (ºC), mean annual rainfall (mm) and 155 
average number of rainy days per year (days). Environmental/demographic variables 156 
included altitude (m), evotranspiration defined as theoretical water requirements by the 157 
vegetation cover (mm), type of soil, distance to wetlands of national importance for water 158 
birds (Ramsar wetlands) (Km) (ICWII, 2017), land cover, presence of Culex pipiens, 159 
presence of Culex theilery, horse herd density and human population density. Human and 160 
horse densities (at municipality level), altitude, evotranspiration, type of soil, distance to 161 
Ramsar wetlands and land cover were provided by the Regional Government of Andalusia 162 
(CMAOT, 2016). The land cover was obtained from the Land Cover Change 2006-2012 163 
(http://land.copernicus.eu/pan-european/corine-land-cover/lcc-2006-2012/view). Raster 164 
maps of presence/absence of C. pipiens and C. theileri were generated based on the criteria 165 
defined by Tran et al. (2013). In brief, they evaluated whether different mosquito species 166 
were present in each CORINE (Coordination of Information on the Environment, 167 
http://www.eea.europa.eu) land cover class based on a literature review and the opinion of 168 
expert entomologists. Therefore, presence or absence of C. pipiens and C. theileri 169 
(dichotomous variable) throughout Andalusia was defined as based on the corresponding 170 
CORINE land cover class at each location. The 2006 CORINE land cover map was 171 
obtained from the European Environment Agency website (http://www.eea.europa.eu). All 172 
predictors were rescaled in rasters format with 100m × 100m spatial resolution, the same 173 
extent and the common UTM 30N projection. Correlation between predictors was assessed 174 
using pairwise Spearman’s rank correlation coefficient (rho). When the correlation between 175 
two variables was 0.5 or higher, only the variable more biologically linked to WNV 176 
occurrence was included in the model. A first “full” MaxEnt model was fit with the 14 177 
potential predictors. Predictors that contributed to 5% or more to the first model were 178 
selected to be run in a final “reduced” model. The final model was evaluated after 179 
partitioning the presence data into a training and a testing using the A k-fold method (Jung 180 
and Hu, 2015). A total of 80% of the WNV outbreaks locations were randomly selected for 181 
model building, whereas the remaining 20% locations were set aside for external validation. 182 
Model performance was assessed using the area under the curve (AUC) of the receiver 183 
operating characteristics curve (ROC) using the “dismo” package in R.  Since AUC has 184 
been shown to be influenced by spatial sorting bias, the calibrated AUC (AUCc) was also 185 
used as suggested by Hijmans et al. (2012). The AUCc provides a more accurate estimate 186 
of the real performance of a model.  187 
The Jackknife training gain test and percent contribution were used to estimate the 188 
contribution of each predictor in the final model. Predictors with the highest training gains 189 
or those that reduced the training gain the most when left out of the model, were considered 190 
the most valuable variables to the model. The final model was then used to generate the 191 
corresponding suitability map for WNV occurrence in Andalusia and a partial plot for the 192 
contribution of each predictors in the model were generated.  193 
 Non-confirmed herds were also overlaid over the WNV suitability map in order to 194 
assess how many of them where located in high risk areas. Specifically, WNV suspected 195 
cases were classified into two categories (“high risk” or “low risk”) based on the median 196 
value of the outbreaks. Map was created using ArcMap version 10.3 (ESRI, Environmental 197 
Systems Resource Institute, www.esri.com). 198 
Results 199 
Descriptive analysis 200 
Between August 2010 and November 2016, 403 suspected horse herds were 201 
investigated, 177 (43.9%) were confirmed as WNV outbreaks (presence of both clinical 202 
symptoms and IgM antibodies or RT-PCR positivity to WNV in at least on horse) (Table 1, 203 
Fig. 1). Within the WNV positive herds, 236 (8.5%) of the 2,779 horses were considered 204 
clinically suspected, of which 215 were confirmed as cases, resulting in a mean WNV-205 
specific morbidity of 7.7%. The mean age of the cases was 7 years (ranging between one 206 
and 22 years), and the census of the infected herds varied from 1 to 325 horses (median = 207 
4). Vaccination programs were not implemented in any of the confirmed or non-confirmed 208 
herds and movement of animals were not performed in these herds one month before the 209 
outbreak was reported. In those WNV positive herds, mean WNV-specific mortality and 210 
WNV-specific case fatality rates were 1.6% and 21.2%, respectively. The most common 211 
clinical symptoms detected in the positive herds were: tiredness/apathy (74.2%), 212 
recumbency (54.8%), muscular tremor (51.6%), ataxia (48.4%), incoordination (48.4%) 213 
and hyperesthesia (45.2%). Fever (32%), anorexia (23%) and convulsion (23%) were also 214 
frequently observed (Fig. 2).  215 
Presence of IgG antibodies was confirmed in 107 (93.0%) of the 115 WNV 216 
confirmed (IgM-positive) herds tested (Table 1). WNV neutralizing antibodies were 217 
observed in 50 (53.2%) of the 94 confirmed herds that could be tested using VNT, with 218 
titers of 1:10 in 20% of them, 1:20 in 30%, 1:40 in 18%, 1:80 in 22% and 1:160 in 10%. 219 
Ten samples (10.6%) could not be analyzed due to cytopathic effects. Besides, presence of 220 
IgG antibodies was detected in 41 of the 133 (30.8%) non-confirmed herds analyzed. WNV 221 
neutralizing antibodies were detected in 14 out of 31 (45.2%) non-confirmed (IgM-222 
negative) herds analyzed by VNT, with titers of 1:20, 1:40, 1:80, 1:240 and 1:640 in two, 223 
five, four, two and one horse herds, respectively.  224 
WNV RNA was found in 14 (4.2%) out of 332 horse herds. Within the positive 225 
herds, WNV RNA was detected in 5 (2.2%) of the 229 blood samples of the analyzed 226 
horses, and in 11 (61.1%) of the 18 CFS from dead or euthanized animals. Two horses were 227 
WNV RNA positive in both blood and CFS. WNV RNA was detected in 2010, 2012, 2013, 228 
2015 and 2016. All RT-PCR positive samples were confirmed as WNV lineage 1.  229 
The first outbreak was reported on the 31th of August 2010 in a horse herd in Cádiz 230 
province (Andalusia). Since then, outbreaks have been reported every year during the 231 
studied period (Fig. 3). The total number of outbreaks per year was: 36 (20.3%) in 2010, 6 232 
(3.4%) in 2011, 3 (1.7%) in 2012, 35 (19.8%) in 2013, 8 (4.5%) in 2014, 17 (9.6%) in 2015 233 
and 72 (40.7%) in 2016. There was a clear seasonal pattern in the outbreak temporal 234 
distribution. Outbreaks were concentrated between the months of July and January, and 235 
peaked in September (Fig. 3). The last three outbreaks were reported on the 11th of 236 
November 2016, two in Badajoz province (Extremadura) and one in Avila province 237 
(Castile and Leon). A total of 82 municipalities located in four different regions have been 238 
affected by the WNV outbreaks that occurred in Spain between 2010 and 2016. Most of the 239 
outbreaks were located in Andalusia (92.7%), followed by Extremadura (3.9%), Castile and 240 
Leon (2.8%) and Castile La Mancha (0.7%). One herd reported outbreaks in three 241 
consecutive years (2014-2016), and there were three other herds that reported outbreaks 242 
two different years (2010-2012, 2014-2015 and 2015-2016). The remaining 173 horse 243 
herds affected reported a single outbreak. 244 
Spatio-temporal analysis 245 
The space-time permutation model identified two statistically significant clusters (P 246 
< 0.001) centered in the west part of Andalusia (Fig. 1 and Table 2). The most likely cluster 247 
included 36 outbreaks and was located in south-western Andalusia (Cádiz province) in 248 
September 2010. Another cluster, with 34 outbreaks, emerged in August 2016 in central 249 
western Andalusia (Seville province).  250 
MaxEnt modeling 251 
Mean annual temperature (49.5% contribution), presence of Culex pipiens (19.5% 252 
contribution), mean annual rainfall (16.1% contribution) and distance to Ramsar wetlands 253 
(14.9% contribution) were identified as the most important predictors for WNV occurrence 254 
in Andalusia (Fig. 4). The AUC of the final MaxEnt model was 0.918 and the AUCc values 255 
0.914. Spearman correlation showed very low correlation between the selected predictors 256 
(see Supplementary Fig. 1). Results of Jackknife and partial plots of the variables in the 257 
final model are shown in Supplementary Fig. 2 and Supplementary Fig. 3. A total of 85 of 258 
the 226 (37.6%) non-confirmed herds were identified in “high risk” areas (Fig. 4).  259 
Discussion 260 
Descriptive analysis 261 
Even though antibodies to WNV had been previously detected in different species 262 
in Spain, clinical cases in horses or humans were not reported until 2010 (García-263 
Bocanegra et al., 2011b). Since 2010, a total of 403 suspected WNV outbreaks were 264 
investigated, and almost half of them (43.9%) were confirmed as outbreaks. The occurrence 265 
of WNV outbreaks over Spain was not homogeneous, as it was higher in the western part 266 
of Andalusia (Fig. 1). However, the temporal evolution confirms important changes in the 267 
spread of WNV in the last decade in Spain, in agreement with those previously reported in 268 
other European countries (ECDC, 2016).  269 
Clinical signs observed in WNV infected horses included both general and nervous 270 
signs, being similar to those previously reported (Murgue et al., 2001; Kutasi et al., 2011; 271 
Porter et al., 2011; van Galen et al., 2013; Bouzalas et al., 2016). The WNV-specific case 272 
fatality found in Spain (21%) was in accordance the values reported in Italy in 2011 (25%) 273 
(Cantile et al., 2000; Autorino et al., 2002), but was lower than that reported in other 274 
countries such as Hungary in 2008 (29%), Greece in 2010 (30%), France in 2000 (45%) 275 
and Morocco in 2003 (56%) (Murgue et al., 2001; Schuffenecker et al., 2005; Kutasi et al., 276 
2011; van Galen et al., 2013; Bouzalas et al., 2016). Discrepancies in fatality rate among 277 
countries may be explained by differences in the viral strains involved or individual factors 278 
(Rios et al., 2010; Porter et al., 2011). In this respect, cross-immunity associated to 279 
previous exposure to other flaviviruses may also influence the clinical presentation of the 280 
disease (Tesh et al., 2002; Rodríguez et al., 2010). Several flaviviruses, including Usutu 281 
virus, Bagaza virus and Meaban virus have circulated in the study area in the last decade 282 
(García-Bocanegra et al., 2012a, Jurado-Tarifa et al., 2016). Consequently, laboratory 283 
analyses are required to confirm or exclude WNV infection.  284 
Given the low viral load and short viremia in horses and humans, the voluntary 285 
vaccination in horses as well as the late appearance of clinical symptoms, frequently when 286 
the viremia phase is over, confirmation of WNV outbreaks is based on both presence of 287 
clinical symptoms and the detection of early IgM antibodies against WNV. Based on that 288 
criteria, 177 (43.9%) of the 403 suspected herds were confirmed as WNV outbreaks. VNT 289 
positivity was only confirmed in 53.2% of the total confirmed herds. Additionally, two 290 
cases were negative by VNT but positive using RT-PCR. Although VNT is recommended 291 
by OIE as the gold standard method for WNV diagnosis particularly in areas with 292 
circulation of other flaviviruses, our results indicate that the combination of clinical 293 
symptoms and detection of IgM antibodies against WNV, may be a good criterion to 294 
confirm a case in specific epidemiological scenarios.  295 
A high percentage of WND cases (93.0%; 107 of the 115 WNV positive herds) 296 
presented both IgM and IgG antibodies. Experimental WNV infections indicate that IgM 297 
antibodies can be found in serum around 7-10 days post-infection (dpi) until 1-3 months, 298 
while IgG-specific antibodies can be detected for several years after infection (Ostlund et 299 
al., 2001; Durand et al., 2002; Castillo-Olivares and Wood, 2004; Bouzalas et al., 2016). 300 
WNV RNA was only detected in blood in 2.2% of the total analyzed animals from positive 301 
herds, which is consistent with the short viremia reported in this species (Bunning et al., 302 
2002). The presence of WNV RNA in 11 of the 18 (61.1%) CFS confirms the higher 303 
persistence of the virus in central nervous system as well as the usefulness of using this 304 
fluid for RNA WNV detection (Kleiboeker et al., 2004). Although both WNV lineages 1 305 
and 2 have been reported in Europe and the Mediterranean Basin (Calistri et al., 2010; Papa 306 
et al., 2011), all RT-PCR positive samples were confirmed as WNV lineage 1. This 307 
coincides with previous studies that reported only WNV lineage 1 in birds, horses and 308 
mosquitoes in Spain (Jiménez-Clavero et al., 2008; García-Bocanegra et al., 2011b; 309 
Vázquez et al., 2011). However, given the active circulation of WNV lineage 2 in other 310 
Mediterranean countries during the last few years (Hernández-Triana et al., 2014), its 311 
introduction and spread in Spain cannot be ruled out (Fros et al., 2015).  312 
The highest risk period for WNV outbreaks occurrence in Spain ranges between 313 
mid-August and mid-November, concentrating 94.4% of the total horse outbreaks. This 314 
temporal distribution of WNV outbreaks is consistent with the findings in other 315 
Mediterranean countries (Murgue et al., 2001; Autorino et al., 2002; Porter et al., 2011; 316 
Kutasi et al., 2011) and USA states with Mediterranean-like climate (CDC, 2017). The 317 
outbreaks confirmed consecutively during the last seven years as well as the detection of 318 
WNV RNA lineage 1 in 2010, 2012, 2013, 2015 and 2016, suggest an endemic circulation 319 
of WNV in Spain. Annual reintroduction of the virus through transportation of migratory 320 
infected birds, infected vectors putatively from Africa or overwintering, may explain 321 
pathways for the endemic circulation observed in Spain in the last years. Further 322 
phylogenetic analyses are needed to elucidate the origin and evolution of the viruses 323 
circulating in Spain.  324 
Spatio-temporal distribution 325 
Andalusia is the region of Spain with the largest populations of horses with about 326 
219,198 animals, and the density ranges between 3.7 and 1.2 horses/km2 in the western and 327 
eastern regions, respectively (MAPAMA, 2016). The provinces of Seville and Cadiz, where 328 
the two clusters were detected, were also consistently associated with the detection of the 329 
three human cases reported in Spain to date (Fig. 3). The strategic location within important 330 
wild birds migratory flyways, the high number of wetlands, environmental conditions, 331 
higher density of competent vectors and the high density of horses, are possible factors 332 
implicated in the higher spread of WNV in this area. 333 
The immunity of the horse population to WNV is directly related with the natural 334 
exposure and the vaccination. Seroprevalence against WNV in horses in Andalusia after the 335 
first WNV epidemic was 7.1% (36/510), being significantly higher in areas where the 336 
outbreaks were reported (García-Bocanegra et al., 2012). Further studies are required to 337 
assess the evolution of the immunity in the horse populations after seven years of WNV 338 
circulation in this region. Even though vaccination is known to be an effective measure for 339 
WNV prevention and control, because of the cost of vaccines, its application is voluntary 340 
and commonly restricted to regions where outbreaks were previously detected. The 341 
secondary cluster was identified in the region of Andalusia with highest horses and human 342 
population density, which highlights the high risk of WNV potential infection in humans. 343 
In fact, confirmed WNV outbreaks in horses is considered an early indicator of the risk of 344 
exposure to humans (Saegerman et al., 2016).  345 
MaxEnt modeling 346 
We have shown that MaxEnt modeling can be successfully applied to emerging 347 
diseases, in which climatic and environmental characteristics play an essential role. The 348 
presented presence-only model showed high accuracy capturing risk areas for WNV 349 
outbreaks (AUCc=0.914). The WNV risk map accurately identifies areas at high risk for 350 
WNV outbreaks in both humans and animals and thus provides a useful tool to design more 351 
accurate and cost-effective surveillance and control programs. Our results were in general 352 
consistence with those previously obtained using Mahalanobis distance analysis (Conte et 353 
al., 2015). Similar risk areas were also identified by Sánchez-Gómez et al. (2017) using a 354 
logistic regression-based spatial model with a limited number of predictors. The suitability 355 
areas obtained in our study provide a much higher spatio-temporal resolution than previous 356 
studies, allowing to refine the implementation of target interventions. Additionally, the 357 
MaxEnt model also highlighted new high risk areas for WNV occurrence (Fig. 4), which 358 
provides valuable information to guide surveillance strategies for early detection of new 359 
cases in currently free areas. Interestingly, the MaxEnt model identified WNV risk areas in 360 
central regions in Andalusia where, although outbreaks have not been reported yet, 361 
seropositivity to WNV has been detected in different species including horses, birds and 362 
wild ruminants (García-Bocanegra et al., 2012b, García-Bocanegra et al., 2016; Jurado-363 
Tarifa et al., 2016). Moreover, a high percentage (37.6%; 85/226) of non-confirmed herds 364 
were located in high suitability areas. This finding, together with the high percentage of 365 
non-confirmed herds positive to IgG antibodies (30.8%; 41/133), most of them (45.2%; 366 
14/31) also confirmed by VNT, indicate that the number of WNV outbreaks confirmed in 367 
horses in Spain may be underestimated. The notification of WND clinically suspected 368 
horses to the official veterinary services, which usually occurs at late stages of the disease, 369 
as well the relatively short duration of WNV-specific IgM antibodies, are possible factors 370 
that can hamper the confirmation of clinically suspected cases.  371 
The final presence-only model mostly relied on climatic and environmental factors 372 
to determine the WNV suitability in Spain between 2010 and 2016. Specifically, mean 373 
annual temperature and mean annual rainfall which were the most important climatic 374 
predictors for WNV occurrence. Areas with mean annual temperature higher than 18º C 375 
were found most risk for WNV (Supplementary Fig. 2). Different studies have reported the 376 
influence of temperature on the risk of WNV transmission (Ben Hassine et al., 2014; Paz, 377 
2015). Increased temperature accelerates both WNV amplification and transmission 378 
through the acceleration of the development of competent vectors, increasing the biting 379 
behavior, increasing the reproductive rate, increasing the duration of the breeding season, 380 
and by reducing the extrinsic incubation period (Chevalier et al., 2014; Paz, 2015). 381 
Moreover, areas with annual precipitation between 550 and 1100 mm were found most risk 382 
for the presence of WNV (Supplementary Fig. 2). These are consistent with the notion that 383 
regions with wet and warm climatic conditions are risk habitats for WNV transmission 384 
(Ozdenerol et al., 2013; Mughini-Gras et al., 2014; Paz, 2015). As the impact of rainfall in 385 
WNV transmission is not as straightforward as temperature, the influence of rainfall on 386 
WNV transmission remains controversial. Even though previous studies demonstrated that 387 
the rainfall is positively correlated with both the presence of mosquitoes and WNV 388 
outbreaks in humans (Papa et al., 2010; Bisanzio et al., 2011; Hartley et al., 2012; 389 
Chevalier et al., 2014), heavy precipitation may have a negative effect on their abundance 390 
through the dilution of nutrients and the flushing of the breeding sites (Koenraadt et al., 391 
2008). Furthermore, drought may concentrate resources for both avian reservoirs and 392 
mosquitoes, leading to more likely contact between both groups of species. 393 
Areas close to Ramsar wetland (< 0.5 km) were also found to be suitable for WNV 394 
occurrence (Supplementary Fig. 2). This finding is consistent with previous observations 395 
(Rodríguez-Prieto et al., 2012; Valiakos et al., 2014; Bargaoui et al., 2015; Sánchez-Gómez 396 
et al., 2017). WNV transmission depends on the co-occurrence in space and time of both 397 
virus, competent vectors and susceptible bird hosts. Wetlands provide suitability habitats 398 
for mosquito larva presence (Bian et al., 2006). Moreover, Ramsar wetlands present a 399 
particularly high diversity and abundance of wild bird species, increasing the risk of WNV 400 
transmission to both natural reservoirs and dead-end hosts close to these areas (Valiakos et 401 
al., 2014).  402 
The final model included the presence of C. pipiens as the second most relevant 403 
predictor of WNV occurrence. This result is consistent with other studies that identified this 404 
mosquito species as the primary vector of WNV in Europe (Hubálek and Halouzka, 1999; 405 
Calistri et al., 2010; Chevalier et al., 2014). Although data on the distribution of Culex 406 
species are still limited in Spain, previous studies have shown that C. pipiens, C. 407 
perexiguus, C. theileri and C. modestus are the main Culex species detected in western 408 
Andalusia (Aranda et al., 2009, Vázquez et al., 2011, García-Bocanegra et al., 2012b). The 409 
absence of C. theileri in the final model could indicate a less relevant role of this vector 410 
species in WNV transmission in the study area. Future studies should be conducted 411 
considering other competent vector species (eg. C. perexiguus and C. modestus) as well as 412 
other environmental and climatic variables for which data was not available in this study 413 
(e.g., relative humidity, seasonality) to assess the implication of these variables in the WNV 414 
occurrence in Spain. 415 
Conclusions 416 
The results obtained in this study contribute to a better understanding of WNV 417 
transmission in Spain. The outbreaks confirmed consecutively during the last seven years, 418 
as well as the detection of WNV RNA lineage 1 in five different periods, suggest an 419 
endemic circulation of the virus in the south part of the country. The spatio-temporal 420 
distribution of WNV outbreaks in Spain was not homogeneous, as significant clusters were 421 
detected in western Andalusia in two non-consecutive years. Additionally, the highest 422 
number of outbreaks reported in 2016 compared to the previous years and the expansion to 423 
northern areas outside Andalusia province, suggests an active circulation and expansive 424 
trend. Therefore, there is a potential risk of WNV spread to previously unaffected areas 425 
within the Iberian Peninsula in the following years. The identification of WNV risk areas 426 
and spatio-temporal clusters in this study can serve to inform risk-based, more cost-427 
effective strategies towards better prevention and control of WND in Spain. In order to 428 
better prevent future WNV cases in the horses and humans, specific measures, including 429 
vaccination programs, risk-based surveillance and outreach and communication of horse 430 
owners and the general public should be implemented in the identified areas. 431 
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Figure legends 681 
 682 
Fig. 1. Spatial distribution of the 177 confirmed WNV outbreaks in Spain between 2010 683 
and 2016.  Black dots indicate outbreaks in horse herds.   684 
Fig. 2. Frequency in which different clinical symptoms associated to WNV infection were 685 
observed in herds affected by WND in Spain (2010-2016). Black and grated bars indicate 686 
general and nervous symptoms, respectively. 687 
Fig. 3. Temporal evolution (in weeks) of WNV outbreaks in Spain during the period 2010-688 
2016. 689 
Fig. 4. Map of Andalusia (southern Spain) showing high risk areas for WNV occurrence. 690 
Color gradient represents the WNV occurrence risk. Black and green dots indicate the 691 
confirmed and non-confirmed WNV outbreaks in horses, respectively. Yellow crosses 692 
indicate WNV outbreaks in human.  693 
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Table legends 695 
 696 
Table 1. Results of the laboratory analyses for WNV in horse herds between August 2010 697 
and November 2016, in southern Spain.  698 
 699 
Table 2. Results of the space-time permutation model for WNV outbreaks in horses 700 
between August 2010 and November 2016, in Andalusia, southern Spain.  701 
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